Targeting BMP-1 enhances anti-tumoral effects of doxorubicin in metastatic mammary cancer: common and distinct features of TGF-β inhibition
These results demonstrated for the first time that the inhibition of BMP-1 activity has therapeutic potential for treatment of metastatic mammary cancer and enhances the anti-tumoral effects of doxorubicin.
Authors
- Azmi Yerlikaya (ORCID: https://orcid.org/0000-0002-0678-0701)
- Chiara Riganti (ORCID: https://orcid.org/0000-0001-9787-4836)
- Seren Haksever
- Nuray Erin (ORCID: https://orcid.org/0000-0002-6116-1970)
- Esra Tavşan
Institutions
- Akdeniz University (TR)
- Kutahya Saglik Bilimleri Universitesi
- University of Turin (IT)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1007/s10549-024-07592-4
- Citations
- 4
- Primary Topic
- TGF-β signaling in diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Akdeniz Üniversitesi